When a physician orders a diagnostic test, they are making a clinical commitment.
They are saying: I need this information to provide you with appropriate care. The test I'm ordering has the potential to guide your treatment, catch a condition early, confirm a diagnosis, or monitor a response. Completing it matters.
The commitment is real. What rarely gets named explicitly is what happens when the infrastructure to complete the test doesn't exist near the patient.
The diagnostic process, as most patients understand it, works like this: the physician order the test, the patient gets their blood drawn, the result comes back, and the physician acts on the information.
What that model assumes — and what fails for millions of patients every year — is that the blood draw is accessible. That a qualified collection site exists within a practical distance. That the nearest draw site is equipped for the specific test that was ordered. That scheduling, transportation, work schedules, and physical capacity align with the draw site's availability.
When any of those assumptions fail, the order goes unfulfilled. Not because the patient chose not to comply. Because the infrastructure that was supposed to make the test accessible didn't reach them.
An uncompleted lab order rarely gets logged as an infrastructure failure. It gets logged as patient non-compliance. That label attributes the failure to the patient rather than to the system that failed to provide the access the physician's order assumed was there.
The consequence is a clinical commitment that goes unmet and a patient who carries the label of non-compliance for a failure that wasn't theirs.
The right to complete a test their physician has ordered is not a luxury. It is a reasonable expectation of a functioning diagnostic system.
Specifically, patients have a right to expect:
That when a physician orders a diagnostic test, the ordering system includes a pathway to complete it — not just an assumption that the patient will figure out the access problem themselves.
That when an order goes uncompleted because of access barriers, the failure is documented as an access failure rather than attributed to the patient as non-compliance.
That rural patients, patients in underserved communities, and patients managing complex conditions have access to the same diagnostic tools as patients in well-served markets.
These expectations aren't unreasonable. They are the baseline of equitable diagnostic care — and they're not yet the baseline of the system as it currently exists.
My One Medical Source® (MOMS) is the Connection for the Collection®. The platform connects specialty diagnostic labs to a national network of credentialed, trained MAPs: Medical Access Points/Providers™ across all 50 states — including the rural counties, smaller MSAs, and underserved communities where the collection infrastructure gap is largest.
Every MAP in the MOMS network is credentialed before their first draw. Every MAP completes test-specific training through the Sticklogistics® platform before collecting for a specific lab. The compliance infrastructure — HIPAA coverage, Business Associate Agreements, chain of custody protocols — is built into the platform.
The work of closing the gap between what patients have a right to expect and what the system currently delivers in infrastructure work. MOMS is how specialty labs do it.